• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒肺炎老年患者的临床特征:病例报告的系统评价

Clinical characteristics of older patients with COVID-19: a systematic review of case reports.

作者信息

Córdova Luisser Dainner Saavedra, Vega Alexander Pieter Mayor, Luján-Carpio Elmer, Parodi José Francisco, Moncada-Mapelli Enrique, Armacanqui-Valencia Isai, Salvador-Ruiz Jhonatanael, Pawer-Pucurimay Dalia, Ydrogo-Cruz Erickson, Chevarría-Arriaga Mylenka Jennifer, Ganoza-Farro Macarena, Meza-Romero Araceli, Zegarra-Rodríguez Cynthia Alejandra, Albán-Murguia Pedro Gustavo, Bailón-Valdez Zaira, Palacios-Garcia Naheilli, Quevedo-La-Torre Danae, Alcós-Mamani Angelica Lizeth, Gómez-Martel Luisa Alisson, Roca-Moscoso Max Antonio, Gamboa-Orozco Martin, Salazar-Granara Alberto

机构信息

Universidad de San Martín de Porres, School of Medicine - Lima, Peru.

Research Centre of Traditional Medicine and Pharmacology, School of Medicine, Universidad de San Martín de Porres - Lima, Peru.

出版信息

Dement Neuropsychol. 2021 Jan-Mar;15(1):1-15. doi: 10.1590/1980-57642021dn15-010001.

DOI:10.1590/1980-57642021dn15-010001
PMID:33907593
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8049578/
Abstract

UNLABELLED

In the context of the current COVID-19 pandemic, higher morbidity and mortality have been reported in older adults. This age group presents physiological changes and its own clinical conditions such as frailty, dementia, among others.

OBJECTIVE

To describe the characteristics of COVID-19 patients, both over and under 80 years old, by conducting a systematic review of the literature describing case reports, and to summarize and critically assess these characteristics.

METHODS

Systematic review. The study was registered on the Registry of Health Research Projects (PRISA) of the Peruvian National Institute of Health (code EI00000631). Five electronic databases (Scopus, PubMed, PubMed Central, LILACS, and SCIELO) were systematically searched during the period between December 31, 2019 and April 16, 2020. The search focused on case reports, case studies, and case series of older people with COVID-19 infection aged over or under 80 years. When selecting the cases, priority was given to clinical and epidemiological profile, laboratory and imaging patterns, and comprehensive geriatric evaluation.

RESULTS

1,149 articles were identified; after applying the filters, a total of 15 publications of case reports and complete records of 27 older adults were obtained. The most frequent age group was between 60 to 69 years old. There is little literature regarding case reports of older adults aged over 80 years. The most frequent parameters were hypertension, fever, cough, respiratory distress, ground-glass opacification in chest radiography and tomography. Furthermore, decrease in PaO/FiO ratio and lymphocytes, and increase in C-reactive protein and Interleukin 6 were observed.

CONCLUSIONS

This systematic review found little available information of patients under 80 years old, and far less for those over 80 years old, and an absence of comprehensive geriatric assessment.

摘要

未标注

在当前新冠疫情背景下,据报道老年人的发病率和死亡率更高。这个年龄组存在生理变化以及自身的临床状况,如虚弱、痴呆等。

目的

通过对描述病例报告的文献进行系统综述,描述80岁及以上和80岁以下新冠患者的特征,并总结和批判性评估这些特征。

方法

系统综述。该研究已在秘鲁国家卫生研究所的卫生研究项目注册登记处(PRISA)登记(代码EI00000631)。在2019年12月31日至2020年4月16日期间,对五个电子数据库(Scopus、PubMed、PubMed Central、LILACS和SCIELO)进行了系统检索。检索重点是80岁及以上或80岁以下新冠感染老年人的病例报告、病例研究和病例系列。在选择病例时,优先考虑临床和流行病学特征、实验室和影像学模式以及综合老年评估。

结果

共识别出1149篇文章;应用筛选条件后,共获得15篇病例报告出版物和27名老年人的完整记录。最常见的年龄组是60至69岁。关于80岁以上老年人病例报告的文献很少。最常见的参数是高血压、发热、咳嗽、呼吸窘迫、胸部X线和断层扫描中的磨玻璃影。此外,观察到动脉血氧分压/吸入氧分数比值和淋巴细胞减少,C反应蛋白和白细胞介素6升高。

结论

这项系统综述发现,关于80岁以下患者的可用信息很少,80岁以上患者的信息更少,且缺乏综合老年评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26ce/8049578/afe00de5f079/1980-5764-dn-15-01-0001-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26ce/8049578/afe00de5f079/1980-5764-dn-15-01-0001-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26ce/8049578/afe00de5f079/1980-5764-dn-15-01-0001-gf01.jpg

相似文献

1
Clinical characteristics of older patients with COVID-19: a systematic review of case reports.新型冠状病毒肺炎老年患者的临床特征:病例报告的系统评价
Dement Neuropsychol. 2021 Jan-Mar;15(1):1-15. doi: 10.1590/1980-57642021dn15-010001.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Publication timeline of chest imaging reporting in children with coronavirus disease 2019 (COVID-19): a systematic review spanning 2020.2019年冠状病毒病(COVID-19)患儿胸部影像报告的发表时间线:一项涵盖2020年的系统评价
Pediatr Radiol. 2022 Sep;52(10):1998-2008. doi: 10.1007/s00247-022-05466-9. Epub 2022 Aug 12.
4
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and Adolescents: A Systematic Review.儿童和青少年严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染:系统评价。
JAMA Pediatr. 2020 Sep 1;174(9):882-889. doi: 10.1001/jamapediatrics.2020.1467.
5
Radiographic Features of COVID-19 in Children-A Systematic Review.儿童新型冠状病毒肺炎的影像学特征——一项系统评价
Children (Basel). 2022 Oct 25;9(11):1620. doi: 10.3390/children9111620.
6
Clinical characteristics of confirmed COVID-19 in newborns: a systematic review.新型冠状病毒肺炎新生儿确诊病例的临床特征:系统评价。
J Matern Fetal Neonatal Med. 2022 Nov;35(22):4386-4397. doi: 10.1080/14767058.2020.1849124. Epub 2020 Nov 19.
7
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease.用于确定在基层医疗或医院门诊就诊的患者是否患有新冠病毒病的体征和症状。
Cochrane Database Syst Rev. 2020 Jul 7;7(7):CD013665. doi: 10.1002/14651858.CD013665.
8
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.意大利伦巴第地区 1591 名 ICU 收治的 SARS-CoV-2 感染患者的基线特征和结局。
JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394.
9
[Symptoms of COVID-19 among older adults: systematic review of biomedical literature].[老年人中新冠病毒病的症状:生物医学文献的系统评价]
Geriatr Psychol Neuropsychiatr Vieil. 2020 Jun 1;18(2):135-140. doi: 10.1684/pnv.2020.0863.
10
Clinical Characteristics and Diagnostic Challenges of COVID-19: An Update From the Global Perspective.从全球视角看 COVID-19 的临床特征和诊断挑战:最新进展。
Front Public Health. 2021 Jan 11;8:567395. doi: 10.3389/fpubh.2020.567395. eCollection 2020.

引用本文的文献

1
Characteristics and Trends of COVID-19 Infection in a Tertiary Hospital in Romania: A Retrospective Study.罗马尼亚一家三级医院新冠肺炎感染的特征与趋势:一项回顾性研究
J Pers Med. 2022 Nov 18;12(11):1928. doi: 10.3390/jpm12111928.
2
The relationship between C-reactive protein and levels of various cytokines in patients with COVID-19: A systematic review and correlation analysis.新型冠状病毒肺炎患者C反应蛋白与多种细胞因子水平的关系:一项系统综述与相关性分析
Health Sci Rep. 2022 Oct 7;5(6):e868. doi: 10.1002/hsr2.868. eCollection 2022 Nov.
3
Never Thought I was Going to be Placed in a Situation Like This: In the Shoes of the Doctor Responsible for Municipal Health, Back in My Country, Perú.

本文引用的文献

1
Imaging Profile of the COVID-19 Infection: Radiologic Findings and Literature Review.新型冠状病毒肺炎感染的影像学表现:放射学发现与文献综述
Radiol Cardiothorac Imaging. 2020 Feb 13;2(1):e200034. doi: 10.1148/ryct.2020200034. eCollection 2020 Feb.
2
Prevalence and prognostic value of elevated troponins in patients hospitalised for coronavirus disease 2019: a systematic review and meta-analysis.2019年冠状病毒病住院患者肌钙蛋白升高的患病率及预后价值:一项系统评价和荟萃分析
J Intensive Care. 2020 Nov 23;8(1):88. doi: 10.1186/s40560-020-00508-6.
3
Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19).
从没想过自己会陷入这样的境地:站在我祖国秘鲁负责市政卫生的医生的角度。
J Popul Ageing. 2022;15(3):803-810. doi: 10.1007/s12062-022-09381-7. Epub 2022 Aug 1.
4
One-Year Report of COVID-19 Impact on Geriatric Patients: a Bio-Psycho-Social Approach.新型冠状病毒肺炎对老年患者影响的一年期报告:生物心理社会视角
Can Geriatr J. 2022 Jun 1;25(2):212-221. doi: 10.5770/cgj.25.553. eCollection 2022 Jun.
5
Adult patients admitted to a tertiary hospital for COVID-19 and risk factors associated with severity: a retrospective cohort study.收治于一家三级医院的 COVID-19 成年患者以及与严重程度相关的危险因素:一项回顾性队列研究。
Rev Inst Med Trop Sao Paulo. 2022 Feb 25;64:e20. doi: 10.1590/S1678-9946202264020. eCollection 2022.
COVID-19 住院患者使用羟氯喹(无论是否联合使用阿奇霉素)导致 QT 间期延长的风险。
JAMA Cardiol. 2020 Sep 1;5(9):1036-1041. doi: 10.1001/jamacardio.2020.1834.
4
Early estimation of the risk factors for hospitalization and mortality by COVID-19 in Mexico.墨西哥对COVID-19导致住院和死亡的风险因素的早期评估。
PLoS One. 2020 Sep 11;15(9):e0238905. doi: 10.1371/journal.pone.0238905. eCollection 2020.
5
Description of patients with severe COVID-19 treated in a national referral hospital in Peru.秘鲁一家国家级转诊医院收治的重症新冠肺炎患者情况描述。
Rev Peru Med Exp Salud Publica. 2020 Apr-Jun;37(2):253-258. doi: 10.17843/rpmesp.2020.372.5437. Epub 2020 Aug 28.
6
Remdesivir for the Treatment of Covid-19 - Preliminary Report. Reply.瑞德西韦治疗新冠病毒病-初步报告。回复。
N Engl J Med. 2020 Sep 3;383(10):994. doi: 10.1056/NEJMc2022236. Epub 2020 Jul 10.
7
Unequal Impact of Structural Health Determinants and Comorbidity on COVID-19 Severity and Lethality in Older Mexican Adults: Considerations Beyond Chronological Aging.结构健康决定因素和合并症对墨西哥老年成年人 COVID-19 严重程度和死亡率的不平等影响:超越年龄的考虑。
J Gerontol A Biol Sci Med Sci. 2021 Feb 25;76(3):e52-e59. doi: 10.1093/gerona/glaa163.
8
Retraction-Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis.撤稿——羟氯喹或氯喹联合或不联合大环内酯类药物治疗新型冠状病毒肺炎:一项多国注册研究分析
Lancet. 2020 Jun 13;395(10240):1820. doi: 10.1016/S0140-6736(20)31324-6. Epub 2020 Jun 5.
9
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.瑞德西韦治疗成人重症 COVID-19 的随机、双盲、安慰剂对照、多中心临床试验。
Lancet. 2020 May 16;395(10236):1569-1578. doi: 10.1016/S0140-6736(20)31022-9. Epub 2020 Apr 29.
10
Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial.羟氯喹治疗主要为轻症和中症的 2019 冠状病毒病患者:开放标签、随机对照试验。
BMJ. 2020 May 14;369:m1849. doi: 10.1136/bmj.m1849.